MI

Dr. Tainsky has developed a technology that takes advantage of the responses of the human immune system to identify cancer-associated proteins that bind to antibodies present in the blood of cancer patients but not in the blood of healthy subjects or those with benign diseases. Dr. Tainsky is working to develop a non-invasive screening test for the early detection of lung cancer by using cancer-associated antigens as biomarkers.

Small cell lung cancer cells produce high amounts of myc protein.  The myc protein makes cancer cells resistant to chemotherapy. Dr. Ljungman is investigating why small cell lung cancer makes high amounts of the myc protein and how this can be reversed.